SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: John Jenco who wrote (1449)7/15/1998 10:53:00 AM
From: Greg Kevorkian  Respond to of 1533
 
With all the selling, who is BUYING!



To: John Jenco who wrote (1449)7/15/1998 11:01:00 AM
From: David Cathcart  Read Replies (1) | Respond to of 1533
 
John,

Pardon my ignorance, as I have not been following this company for many years as you have. However, it strikes me that we were all invested in Onconase, and the drug failed. Was there something that Alfacell management did, or did not do, to make that happen? Is there something that we could have done to make the drug work better? These are sincere questions, please treat them as such. I'm reeling in pain too.

I for one want to study this case carefully and learn what I can. One loss like this is more than enough.

David



To: John Jenco who wrote (1449)7/15/1998 11:29:00 AM
From: Fish  Respond to of 1533
 
John - unfortunately there may be very little to take control of. I understand your frustration but don't see any criminal charges. As pointed out in all the prospectus, this is a development company and the risks are great.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News